PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 5, 2025Frontiers in Immunology15 citationsOpen Access

S100 proteins as a key immunoregulatory mechanism for NLRP3 inflammasome

View Full Paper
SAShahinur ActerQLQing Lin

Key Points

  • S100 proteins significantly modulate the nlrp3 inflammasome pathway, impacting immune responses in various disorders.
  • Key evidence includes the role of DAMP molecules like S100A8 and S100A9 in stimulating inflammation and sustaining immune responses.
  • The review analyzes feedback interactions between nlrp3 inflammasome, S100 proteins, and Gasdermin D, emphasizing implications for pulmonary hypertension.
  • Understanding S100 proteins' functions may enable new strategies for managing autoimmune conditions and enhancing immunity.

Abstract

The S100 superfamily of proteins consists of Ca2+-binding proteins characterized by the EF-hand motif. Certain members of this protein family, such as S100A8, S100A9, and S100A12, have been effectively utilized as biomarkers for the detection and evaluation of prognosis in immunological diseases. These proteins are also identified as damage-associated molecular pattern (DAMP) molecules, which exhibit significant upregulation in various autoimmune disorders, cancers, and neurodegenerative diseases. Following tissue injury, necrotic or immune cells release or secrete DAMPs to initiate inflammatory responses. This signaling further creates autocrine and paracrine positive feedback loops that amplify and sustain the inflammatory response. The NLRP3 inflammasome pathway is a pivotal component in these DAMP-induced immune regulatory mechanisms. This review summarizes the regulatory roles of S100 protein family in NLRP3 inflammasome signaling and their functions in innate and adaptive immunity, with an emphasis on pulmonary hypertension. Moreover, we examine the interactive feedback mechanisms among NLRP3 inflammasome, S100A8/A9, and Gasdermin D, exploring their implications in autoimmune diseases.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Acter et al. (2025) studied this question.

synapsesocial.com/papers/68bb3d552b87ece8dc955e61https://doi.org/10.3389/fimmu.2025.1663547
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Relationship of S100 Proteins with Neuroinflammation2025
  2. 2NLRP3, NLRP6, and NLRP12 are inflammasomes with distinct expression patterns2024 · 1 citations
  3. 3NLRP3 and beyond: inflammasomes as central cellular hub and emerging therapeutic target in inflammation and disease2025 · 49 citations
  4. 4S100A9 promotes inflammasome-dependent autoinflammation by blocking the degradation of SYK tyrosine kinase2025
  5. 5Molecular mechanisms of NLRP3 inflammasome activation2026 · 17 citations